IMUNOR® Preparation in the Prevention of COVID-19

NCT04710381 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
56
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital Ostrava